Cargando…

Identification of a Dual Inhibitor of Secreted Phospholipase A(2) (GIIA sPLA(2)) and SARS-CoV-2 Main Protease

The development of novel agents to combat COVID-19 is of high importance. SARS-CoV-2 main protease (M(pro)) is a highly attractive target for the development of novel antivirals and a variety of inhibitors have already been developed. Accumulating evidence on the pathobiology of COVID-19 has shown t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theodoropoulou, Maria A., Koutoulogenis, Giorgos S., Zhang, Linlin, Akrani, Ifigeneia, Mikros, Emmanuel, Hilgenfeld, Rolf, Kokotos, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414318/ https://www.ncbi.nlm.nih.gov/pubmed/36015109 http://dx.doi.org/10.3390/ph15080961

Ejemplares similares

Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation
por: Du, Huan, et al.
Publicado: (2023)

2-Oxoester Phospholipase A(2) Inhibitors with Enhanced Metabolic Stability
por: Koutoulogenis, Giorgos S., et al.
Publicado: (2020)

The Roles of sPLA(2)s in Skin Homeostasis and Disease
por: Yamamoto, Kei, et al.
Publicado: (2023)

Discovery of AZD2716: A Novel Secreted Phospholipase A(2) (sPLA(2)) Inhibitor for the Treatment of Coronary Artery Disease
por: Giordanetto, Fabrizio, et al.
Publicado: (2016)

sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor
por: Pan, Yangbin, et al.
Publicado: (2014)

Nitro Fatty Acids (NO(2)-FAs): An Emerging Class of Bioactive Fatty Acids
por: Koutoulogenis, Giorgos S., et al.
Publicado: (2021)

Distinct expression pattern of the full set of secreted phospholipases A(2) in human colorectal adenocarcinomas: sPLA(2)-III as a biomarker candidate
por: Mounier, C M, et al.
Publicado: (2008)

High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA(2)-IIE and sPLA(2)-V Expression in Macrophages
por: Zhu, Shu, et al.
Publicado: (2016)

A Representative GIIA Phospholipase A(2) Activates Preadipocytes to Produce Inflammatory Mediators Implicated in Obesity Development
por: Leiguez, Elbio, et al.
Publicado: (2020)

Alternative Targets for sPLA2 Activity: Role of Membrane-Enzyme Interactions
por: Alekseeva, Anna S., et al.
Publicado: (2023)

Secretory phospholipase A2 (sPLA2), procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis and differentiation of septic shock and non-septic shock
por: Anglès, O, et al.
Publicado: (2000)

CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department
por: Tan, Toh Leong, et al.
Publicado: (2016)

Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis
por: Li, Kaijun, et al.
Publicado: (2010)

Interactions of pharmacologically active snake venom sPLA(2) with different cell lines
por: Doumanov, Jordan, et al.
Publicado: (2014)

2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A(2)
por: Kokotou, Maroula G., et al.
Publicado: (2017)

The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults—A systematic review
por: Tan, Toh Leong, et al.
Publicado: (2017)

Hemolytic activity and platelet aggregation inhibitory effect of vipoxin's basic sPLA(2) subunit
por: Stoykova, Silviya, et al.
Publicado: (2013)

Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA
por: Dong, Tianyi, et al.
Publicado: (2017)

Modulation of Airway Expression of the Host Bactericidal Enzyme, sPLA2-IIA, by Bacterial Toxins
por: Wu, Yongzheng, et al.
Publicado: (2023)

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A(2) (GIVA cPLA(2))
por: Psarra, Anastasia, et al.
Publicado: (2018)

Molecular Characterization and In Silico Analyses of Maurolipin Structure as a Secretory Phospholipase A(2) (sPLA(2)) from Venom Glands of Iranian Scorpio maurus (Arachnida: Scorpionida)
por: Soltan-Alinejad, Parisa, et al.
Publicado: (2022)

Correction to “Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A(2) (GIVA cPLA(2))”
por: Psarra, Anastasia, et al.
Publicado: (2019)

High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome
por: Ahmad, Nurul Saadah, et al.
Publicado: (2020)

sPLA2 Wobbles on the Lipid Bilayer between Three Positions, Each Involved in the Hydrolysis Process
por: Kuzmina, Natalia, et al.
Publicado: (2022)

(Thio)urea-mediated synthesis of functionalized six-membered rings with multiple chiral centers
por: Koutoulogenis, Giorgos, et al.
Publicado: (2016)

Inhibition of sPLA(2)-IIA Prevents LPS-Induced Neuroinflammation by Suppressing ERK1/2-cPLA(2)α Pathway in Mice Cerebral Cortex
por: Xiang, Yanxiao, et al.
Publicado: (2013)

Structure Activity Relationship and Molecular Docking of Some Quinazolines Bearing Sulfamerazine Moiety as New 3CLpro, cPLA2, sPLA2 Inhibitors
por: Hussein, Mohammed Abdalla, et al.
Publicado: (2023)

A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells
por: Martín, Rubén, et al.
Publicado: (2017)

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease †
por: Göhl, Matthias, et al.
Publicado: (2022)

Bioaffinity Fishing Procedure Using Secretory Phospholipase A2 for Screening for Bioactive Components: Modulation of Pharmacological Effect Induced by sPLA2 from Crotalus durissus terrificus by Hispidulin from Moquiniastrum floribundum
por: dos Santos Junior, Adeilso Bispo, et al.
Publicado: (2020)

Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
por: Zhang, Linlin, et al.
Publicado: (2021)

Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial infection
por: Tan, Toh Leong, et al.
Publicado: (2021)

Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A(2) (sPLA(2)) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells
por: Najahi-Missaoui, Wided, et al.
Publicado: (2020)

Inhibition of Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice
por: Bone, Robert N., et al.
Publicado: (2015)

Context-dependent effect of sPLA(2)-IIA induced proliferation on murine hair follicle stem cells and human epithelial cancer
por: Chovatiya, Gopal L., et al.
Publicado: (2019)

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
por: Zhang, Linlin, et al.
Publicado: (2020)

An Evaluation of 3-Rhamnosylquercetin, a Glycosylated Form of Quercetin, against the Myotoxic and Edematogenic Effects of sPLA (2) from Crotalus durissus terrificus
por: Toyama, Daniela de Oliveira, et al.
Publicado: (2014)

Characterization of FKGK18 as Inhibitor of Group VIA Ca(2+)-Independent Phospholipase A(2) (iPLA(2)β): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes
por: Ali, Tomader, et al.
Publicado: (2013)

Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA(2)-IIA expression in astrocytes and microglia
por: Sheng, Wenwen, et al.
Publicado: (2011)

Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease
por: Cooper, Mark S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_klk549ktfr3psim950b122a0g1